do probiotics help baby reflux?

Modestly, and only for visible spit-up. The largest RCT (Indrio 2014, 589 newborns) found L. reuteri DSM 17938 reduced regurgitation by 0.4 episodes per day compared to placebo — a small effect. Both groups improved substantially over 90 days, largely due to natural resolution. For silent reflux (acid irritation without visible spit-up), there is no evidence that probiotics help.

does BioGaia (L. reuteri) help with baby spit-up?

Slightly. BioGaia Protectis (L. reuteri DSM 17938) reduced visible regurgitation episodes by 0.4 per day in the key 589-infant trial. It may also accelerate gastric emptying, which is the most credible mechanism for reducing reflux. It is safe and reasonable to try if visible spit-up is the concern — but set realistic expectations, as the effect is modest.

what is the difference between L. reuteri and B. infantis for babies?

They are doing entirely different things. L. reuteri DSM 17938 (BioGaia) modulates gut motility and has evidence for reducing colic and visible regurgitation. B. infantis (Evivo, Laveen) is a colonising probiotic that digests human milk oligosaccharides and supports gut microbiome development in breastfed infants. B. infantis has no meaningful evidence for treating reflux.

is BioGaia worth trying for a reflux baby?

If your baby has classic visible spit-up, BioGaia Protectis is safe, reasonably priced, and might modestly reduce regurgitation episodes. If your baby has silent reflux with feed aversion, severe sleep disruption, and back-arching but minimal spit-up, the evidence does not support probiotics as a meaningful intervention — feed thickeners or acid suppression medication are better-supported options.

Probiotics for Baby Reflux: What the Studies Really Show

Q: do probiotics help with silent reflux in babies?

No evidence supports this. The probiotic studies for infant reflux measured visible regurgitation episodes counted by parents — not acid exposure on pH probe, not oesophageal irritation, not pain. Silent reflux is primarily an acid contact problem. Probiotics have not been shown to reduce acid contact with the oesophageal lining.

You’ve seen BioGaia Protectis drops at the pharmacy. The packaging mentions “reduced crying” and “digestive comfort.” Your baby has reflux. You’re exhausted. The drops are £30 and you’ll try anything.

So do they work?

The honest answer is: maybe, a little, for visible spit-up. For silent reflux specifically, the evidence is thinner than most parents are told.

Here’s what the studies actually show.

The Main Study: Indrio 2014

The most cited research on L. reuteri DSM 17938 (the specific probiotic strain in BioGaia Protectis) for infant GI symptoms is a multicenter, double-blind, placebo-controlled RCT by Indrio et al., published in JAMA Pediatrics in 2014 (PMID 24424513).

Study design: 589 newborns (under 1 week old) randomised to L. reuteri DSM 17938 drops (10⁸ CFU/day) or placebo for 90 days. Parents recorded crying time, regurgitation episodes, and stool frequency daily.

Results for regurgitation:

Probiotic group: regurgitation reduced from baseline to 2.9 episodes/day at 3 months
Placebo group: 3.3 episodes/day at 3 months
Difference: 0.4 fewer regurgitation episodes per day

Before you buy the drops based on that, read it again. 0.4 episodes per day. Not zero. Not even one less. Four-tenths of one episode.

The bigger-looking number (from 4.6 to 2.9) reflects that both groups improved substantially over time — which is what infant reflux does naturally as babies grow. The actual probiotic-attributable benefit is the difference between the two groups at endpoint: 0.4 episodes per day.

What this study measured: Visible regurgitation episodes counted by parents. Not acid exposure on pH probe. Not oesophageal irritation. Not pain. Not sleep quality. Visible spit-up.

For a baby with classic regurgitation (spitting up a lot), 0.4 fewer visible episodes per day might make your life marginally cleaner. For a baby with silent reflux (where acid goes up and comes back down without exiting), this study tells you almost nothing — because it didn’t measure what’s happening in silent reflux.

The Gastric Emptying Study (PMID 21114493)

Indrio et al. also published an earlier RCT in 2011 looking at whether L. reuteri affects gastric emptying — the speed at which the stomach empties into the small intestine. Slow gastric emptying can worsen reflux by keeping more liquid in the stomach for longer.

Study design: 42 infants with functional GER randomised to L. reuteri DSM 17938 or placebo for 30 days. Gastric emptying measured by real-time ultrasound.

Results:

Gastric antral area (a proxy for how full the stomach is) was significantly smaller in the probiotic group (p = 0.01)
Delta in gastric emptying rate was significantly increased in the probiotic group (p = 0.01)
Regurgitation episodes per day were significantly reduced in the probiotic group (p < 0.001)

This is more interesting than the 2014 study. L. reuteri appears to accelerate gastric emptying — giving stomach acid less time to pool and reflux. The mechanism is plausible and the results were statistically significant.

Limits: 34 infants completed the study (the other 8 dropped out). No specific data on how much regurgitation was reduced in absolute terms. No long-term follow-up. Small sample means the confidence intervals are wide even if p-values look good.

The gastric emptying mechanism is the most mechanistically credible argument for why L. reuteri might help with reflux. But 34 infants is a small foundation.

The 2021 Meta-Analysis (PMC8710121)

A 2021 systematic review and meta-analysis (Harding et al., Maternal & Child Nutrition) pooled available RCT data on probiotics for infant regurgitation prevention and treatment.

Meta-analysis of 3 studies on regurgitation frequency (N = 560):

Mean difference: −1.79 episodes/day (95% CI: −3.30 to −0.27) in favour of probiotics
Heterogeneity: 96%

That last number is the problem. An I² of 96% means the studies in the meta-analysis were measuring something so different from each other that pooling their results is statistically questionable. Different strains, different populations, different endpoints, different follow-up periods — combining them and treating the result as a unified answer doesn’t hold up well.

The review authors themselves concluded: “The currently available evidence does not support or refute the efficacy of probiotics for the prevention and treatment of infant regurgitation.”

The mean difference of −1.79 sounds more impressive than Indrio 2014’s −0.4, but when you account for the 96% heterogeneity, this number should be treated with significant scepticism. The wide confidence interval (−3.30 to −0.27) tells the same story: the real effect could be anywhere from clinically meaningful to near-zero.

L. reuteri vs B. infantis: They’re Doing Different Things

BioGaia Protectis (L. reuteri DSM 17938) and products like Laveen or Evivo (B. longum subsp. infantis, often marketed as B. infantis) are both sold as probiotic drops for babies. They are not interchangeable and they don’t work through the same mechanism.

L. reuteri DSM 17938:

Produces reuterin (an antimicrobial compound)
Produces histamine (which may modulate gut motility and reduce colic-related pain)
Most evidence is on colic, regurgitation, and gastric motility
Transient coloniser — doesn’t permanently alter the gut microbiome

B. infantis (B. longum subsp. infantis):

Specialised gut coloniser for breastfed infants
Digests human milk oligosaccharides (HMOs) from breastmilk, producing short-chain fatty acids including acetate and lactate
Lowers gut pH, which competitively excludes pathogenic bacteria
Supports gut barrier function and microbiome diversity
Evidence base is primarily on microbiome development, immune modulation, and eczema risk — NOT on reflux or regurgitation
Can permanently colonise the infant gut (unlike L. reuteri)

If someone recommends B. infantis for reflux, they’re extrapolating beyond the evidence. B. infantis is a good probiotic for gut health in breastfed infants. It is not a reflux treatment. The mechanisms don’t overlap.

Why Probiotics Won’t Fix Silent Reflux

Even if you accept the most optimistic reading of the probiotic data — let’s say L. reuteri genuinely reduces visible regurgitation by 1–2 episodes/day — this doesn’t translate to silent reflux.

Silent reflux isn’t primarily a volume problem. The baby isn’t bringing up too much; they’re bringing up acid that causes mucosal irritation before being swallowed back. Reducing visible regurgitation frequency through slightly faster gastric emptying doesn’t necessarily reduce the acid contact time that’s causing the pain.

The studies that showed probiotic benefit measured visible regurgitation episodes counted by parents. Not pH-probe acid exposure. Not oesophageal impedance. Not sleep quality. Not pain scores.

For silent reflux, you need to reduce acid contact with the oesophageal lining. Probiotics have not been shown to do this.

What Probiotics Are Actually Good For

In breastfed infants, there’s genuine evidence that the infant gut microbiome has changed significantly over the past century, with B. infantis becoming much rarer (largely due to formula supplementation, antibiotic use, and C-section delivery affecting colonisation). Supplementing B. infantis in breastfed infants does colonise the gut, does lower stool pH, and does appear to support microbiome diversity.

L. reuteri DSM 17938 has the strongest evidence of any probiotic for infantile colic — several RCTs show it reduces crying time in breastfed colicky infants by roughly 50 minutes/day (systematic review: Sung et al., 2018). That’s a real and clinically meaningful effect.

Neither of these is the same as treating silent reflux.

The Honest Verdict

Claim	What the evidence says
L. reuteri reduces visible regurgitation	Yes — by about 0.4 episodes/day (Indrio 2014)
L. reuteri accelerates gastric emptying	Possibly — small study, plausible mechanism
Probiotics fix silent reflux	No evidence for this
B. infantis treats reflux	Wrong mechanism — this is a microbiome colonisation product
Meta-analysis shows strong benefit	96% heterogeneity makes the pooled result unreliable

If your baby has classic regurgitation (visible spit-up) and it’s your main concern, L. reuteri at 5 drops/day is safe, reasonably cheap, and might take the edge off slightly. Reasonable to try.

If your baby has silent reflux — arching, feed aversion, wet breathing, severe sleep disruption with no visible spit-up — probiotics are unlikely to be the answer. The evidence for feeding thickeners or (if necessary) acid-suppressing medication is stronger for your situation.

Key studies referenced: Indrio et al. 2014, JAMA Pediatrics (PMID 24424513); Indrio et al. 2011, gastric emptying RCT (PMID 21114493); Harding et al. 2021 meta-analysis (PMC8710121); Sung et al. 2018 colic systematic review.